South Dakota legislation · 101st Legislature (2026)
South Dakota HB1169: classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Status: Signed into law, March 9, 2026
What the bill says
An Act ENTITLED An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses.
From the enrolled text, March 1, 2026:
An Act ENTITLED An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses. Be it enacted by the Legislature of the State of South Dakota: Section 1. That a NEW SECTION be added to chapter 34-20B: Any material, compound, mixture, or preparation that contains medetomidine is a Schedule III controlled drug or substance, except in the following cases: (1) Dispensing, prescribing, or administering, to an animal, a drug that contains medetomidine and has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2026); (2) Dispensing, prescribing, or administering medetomidine to an animal, as permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2026); (3) Manufacturing, distributing, or using medetomidine as an active pharmaceutical ingredient for manufacturing an animal drug: (a) Approved under 21 U.S.C. § 360b (January 1, 2026); or (b) Issued an investigational use exemption under 21 U.S.C. § 360b(j) (January 1, 2026); (4) Manufacturing, distributing, or using a medetomidine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or (5) Any other use approved or permissible under 21 U.S.C. §§ 301 to 399i, inclusive (January 1, 2026). An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses. I certify that the attached Act originated in the:Houseas Bill …
Sponsors
- Josephine Garcia (R, HD-005) · primary sponsor
- Tamara Grove (R, SD-026) · primary sponsor
- Bobbi Andera (R, HD-010)
- Jana Hunt (R, HD-028)
- Travis Ismay (R, HD-028)
- Phil Jensen (R, 33)
- Dylan Jordan (R, HD-004)
- Al Novstrup (R, HD-003)
- Kathy Rice (R, HD-029)
- Brandei Schaefbauer (R, HD-003)
Latest actions
- : Signed by the Governor
- : Delivered to the Governor
- : Signed by the President
- : Signed by the Speaker
- : Do Pass
- : Certified uncontested, placed on consent
- : Do Pass
- : Scheduled for hearing
- : First read in Senate and referred to Health and Human Services
- : Do Pass
Votes
- Do Pass (February 26, 2026): 32 yea, 0 nay, passed
- Do Pass (February 25, 2026): 7 yea, 0 nay, passed
- Do Pass (February 11, 2026): 63 yea, 3 nay, passed
- Do Pass (February 10, 2026): 11 yea, 0 nay, passed
Subjects: Public Health and Safety, Controlled Substances
Common questions
- What is HB1169?
- HB1169 is a bill in the South Dakota Legislature (101st Legislature (2026)): classify medetomidine as a Schedule III controlled substance and establish permissible uses.
- What does HB1169 do?
- In its own words: An Act ENTITLED An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses.
- What is the status of HB1169?
- Signed into law as of March 9, 2026. Latest action: Signed by the Governor (March 9, 2026).
- Who sponsored HB1169?
- Josephine Garcia (R, HD-005), with 9 co-sponsors.
- Where is the official record for HB1169?
- On the South Dakota Legislature website: https://sdlegislature.gov/Session/Bill/27007
Source: official South Dakota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.